0001237899-13-000027.txt : 20130508 0001237899-13-000027.hdr.sgml : 20130508 20130508175138 ACCESSION NUMBER: 0001237899-13-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130506 FILED AS OF DATE: 20130508 DATE AS OF CHANGE: 20130508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13825848 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-05-06 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP & General Mgr Industrial O Common Stock 2013-05-06 4 M 0 3902.0 16.8 A 10736 D Common Stock 2013-05-06 4 M 0 29048.0 16.8 A 39784 D Common Stock 2013-05-06 4 F 0 1873.0 260.44 D 37911 D Common Stock 2013-05-06 4 F 0 13450.0 260.44 D 24461 D Common Stock 2013-05-07 4 S 0 700.0 260.88 D 23761 D Common Stock 2013-05-07 4 S 0 10988.0 261.56 D 12773 D Common Stock 2013-05-07 4 S 0 2037.0 262.15 D 10736 D Common Stock 1363 I By 401(k) Plan Incentive Stock Option (right to buy) 16.8 2013-05-06 4 M 0 3902.0 D 2018-12-17 Common Stock 3902 0 D Non-Qualified Stock Option (right to buy) 16.8 2013-05-06 4 M 0 29048.0 D 2018-12-17 Common Stock 29048 52500 D Represents volume-weighted average price of sales of 700 shares of Company stock on May 7, 2013 at prices ranging from $260.79 to $260.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. Represents volume-weighted average price of sales of 10,988 shares of Company stock on May 7, 2013 at prices ranging from $261.01 to $261.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. Represents volume-weighted average price of sales of 2,037shares of Company stock on May 7, 2013 at prices ranging from $262.03 to $262.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2013 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Daniel P. Van Plew 2013-05-07